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Abstract
The prevalence of calcium oxalate (CaOx) uroliths detected in cats with lower urinary tract disease has shown a sharp increase over
the last decades with a concomitant reciprocal decrease in the occurrence of struvite (magnesium ammonium phosphate) uroliths.
CaOx stone-preventative diets are available nowadays, but seem to be marginally effective, as CaOx urolith recurrence occurs in patients
fed these diets. In order to improve the preventative measures against CaOx urolithiasis, it is important to understand its aetiopathogenesis.
The main research focus in CaOx formation in cats has been on the role of Ca, whereas little research effort has been directed towards the
role and origin of urinary oxalates. As in man, the exogenous origin of urinary oxalates in cats is thought to be of minor importance,
although the precise contribution of dietary oxalates remains unclear. The generally accepted dietary risk factors for CaOx urolithiasis
in cats are discussed and a model for the biosynthetic pathways of oxalate in feline liver is provided. Alanine:glyoxylate aminotransferase 1
(AGT1) in endogenous oxalate metabolism is a liver-specific enzyme targeted in the mitochondria in cats, and allows for efficient
conversion of glyoxylate to glycine when fed a carnivorous diet. The low peroxisomal activity of AGT1 in cat liver is compatible with the
view that felids utilised a low-carbohydrate diet throughout evolution. Future research should focus on understanding de novo
biosynthesis of oxalate in cats and their adaptation(s) in oxalate metabolism, and on dietary oxalate intake and absorption by cats.
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Introduction
Urolithiasis is the condition in which calculi are formed in
the urinary tract from initially dissolved minerals and/or
organic compounds. In domestic cats, the primary stones
are composed of calcium oxalate (CaOx) monohydrate or
dihydrate and struvite (magnesium ammonium phosphate
hexahydrate). Less common stones are purines (i.e.
ammonium urate, sodium (calcium) urate, potassium
urate, uric acid dihydrate and xanthine), calcium phos-
phate, matrix, cystine and silica uroliths(1).
Urolithiasis in domestic cats is, after feline idiopathic
cystitis (FIC), the second most common cause of lower
urinary tract disease (LUTD)(2,3). Studies with the aim to
determine the incidence rates for urolithiasis have not
been conducted in cats. Estimates on incidence rates
reported in the literature are largely based on morbidity
rates seen in veterinary practices, with estimates varying
between 0·2 and 0·7 %(4,5).
Over the past 30 years, a progressive increase in the
prevalence of CaOx uroliths in cats diagnosed with LUTD
has been reported in the USA(1), with a similar trend
being observed in Western Europe(6). During the early
1980s, CaOx was detected in only 2 % of all feline uroliths
submitted to the Minnesota Urolith Center, whereas struvite
was detected in 78 % of the uroliths submitted (Fig. 1)(1).
However, in the mid-1990s, together with a rapid increase
in the total number of uroliths submitted for analysis, a
notable shift in the submitted types of uroliths has been
observed(7). In the mid-1980s, the submitted CaOx uroliths
noticeably increased(8), reaching 55 % in 2002 in the USA(1)
and 61 % in 2003 in Western Europe(6). Since 2003 a slight
decline in the percentage of CaOx uroliths has been
observed, reaching 41 % in 2007. This decline comes
along with a reciprocal increase in the frequency of struvite
uroliths, up to 49 % in 2007(1). The amount of less common
uroliths (i.e. purines, calcium phosphate, etc) submitted
for analysis has remained fairly constant at about 10 %(1).
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The same general trend in urolith composition can
be observed in dogs but is less extreme compared
with cats(1,6).
It is generally thought that the concomitant increase in
the occurrence of CaOx uroliths with the reciprocal
decrease in struvite until 2003 reflects the widespread
use of struvite urolith-preventive diets since the mid-
1980s(9,10). These acidifying diets, often with reduced
quantities of Mg, are believed to promote calciuria and
reduce urinary Mg concentrations, both being risk factors
for CaOx urolith formation(10,11). The progressive decrease
in occurrence of CaOx uroliths from 2003 until 2007
may be associated with the improvement of adult main-
tenance and therapeutic diets to minimise risks for
CaOx crystalluria.
Despite the use of urolith-preventive diets over the past
decades, the prevalence of CaOx uroliths in cats remains
substantial. In order to further decrease the incidence of
CaOx urolithiasis in cats, understanding of the aetiopatho-
genesis of CaOx urolithiasis is essential. The purpose of the
present review is to discuss dietary risk factors for CaOx
urolith formation in cats, with an emphasis on the origin
of urinary oxalates. Endogenous biosynthesis of oxalate
in the mammalian liver is reviewed and recommendations
for research in order to reduce feline CaOx urolithiasis by
dietary intervention are provided.
Risk factors
Several risk factors have been identified for CaOx urolith
formation in cats. The risk of developing CaOx uroliths
appears to increase with age, with cats aged 7–10 years
showing the highest predisposition(12). Other predisposing
factors seem to be sex and reproductive status, with male
cats more commonly affected (59 %)(12), and 95 % of cats
with CaOx urolithiasis being neutered. However, the
imbalance of reproductive status in the population of cats
(for example, 78 % of cats examined at primary veterinary
practices in the USA were neutered)(4) might be a con-
founding factor. In Burmese, Himalayan and Persian cats,
a predisposition to develop CaOx uroliths has been
observed, indicating that genetic background also contrib-
utes to CaOx urolithiasis(10,12,13). Nevertheless, considering
the short time span in which the types of feline uroliths
have changed over the past three decades (Fig. 1), it is
highly unlikely that animal-related factors have made a sig-
nificant contribution to this observed trend, as opposed to
nutritional and husbandry factors. Changes in nutrition are
thought to be one of the main reasons for the epidemiolo-
gic shift in urolith type in cats(1).
Urinary concentrations of Ca and oxalate play a key role
in CaOx urolith formation. Factors indirectly influencing
the formation of CaOx crystals are urinary volume, pH,
citrate and glycosaminoglycans (GAG) concentration. The
relationship between various dietary components and the
risk factors for CaOx urolith formation are outlined in
Fig. 2. Dietary components able to influence urine
volume, urinary oxalate excretion, urinary Ca excretion,
urine pH (acidosis) and urinary citrate and GAG levels
(see Fig. 2) will be discussed in more detail.
Urine volume
Theoretically, a high fluid intake could inhibit CaOx urolith
formation since it dilutes the urine, thereby lowering the
urinary concentrations of Ca and oxalate and, in turn, the
crystallisation of CaOx in the urinary tract. Enhancing
urine volume may also increase the frequency of urination,
which would reduce crystalloid and crystal transit time
along the urinary tract, thereby reducing the potential for
crystal growth(14). Therefore, measures to increase water
intake to promote high urine volume can be considered
Year
19
81
19
82
19
83
19
84
19
85
19
86
19
87
19
88
19
89
19
90
19
91
19
92
19
93
19
94
19
95
19
96
19
97
19
98
19
99
20
00
20
01
20
02
20
03
20
04
20
05
20
06
20
07
100
90
80
70
60
Pe
rc
e
n
ta
ge
50
40
30
20
10
0
Fig. 1. Feline urolith distribution in the USA from 1981 until 2007(1): magnesium ammonium phosphate hexahydrate ( ); calcium oxalate ( ); calcium phosphate
( ); purine ( ); matrix ( ); other ( ).
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as one of the best approaches to prevent urolith recur-
rence. A higher water intake can be achieved by feeding
diets with high moisture and/or Na content.
Dietary factors affecting urine volume. Data in the
literature indicate that feeding high-moisture diets to
adult cats leads to a slightly higher total water intake
leading to an increased urine volume(15,16). When high
(82 %)-moisture diets are fed, urine output is increased
by 57·4 % compared with low (10 %)-moisture diets(15). In
a retrospective case–control study with 173 cats with
CaOx uroliths, it was found that cats fed (canned) diets
containing the highest moisture contents (77·4 to 81·2 %)
were only about one-third as likely to develop CaOx uro-
liths compared with cats fed (dry kibble) diets low in
moisture (7·0 to 7·9 %)(9). The purpose of the latter study
was to identify dietary factors associated with the increase
in occurrence of CaOx uroliths. The dietary factors studied
were moisture content, protein, carbohydrate, fat and fibre
content, but also Ca, P, Mg, Na, K and chloride content and
urine-acidifying potential. Of these factors, the moisture
content of the diet seemed to have the strongest associ-
ation with CaOx urolith formation in cats(9). The favour-
able effect of a high water intake on LUTD in general
was also reported by Markwell et al.(14), who stated that
recurrence rates of signs in cats classified as having idio-
pathic LUTD, or FIC, may be more than halved when
affected animals are maintained on high-, rather than
low-, moisture content diets. Gunn-Moore & Shenoy(17)
observed a significantly lower urine specific gravity in
cats with FIC when they were fed more canned cat food
as well.
The increased water intake when feeding moist diets
might not only be due to its higher moisture content, but
also because its higher mineral (ash) and protein content
(evoking a higher renal solute load) may stimulate drink-
ing(18,19). This is in line with the finding that a high
intake of animal protein is accompanied by increased
water consumption and urine volume in cats(20). Taking
into account the overall beneficial effect of high-moisture
diets by increasing urine volume, and therefore diluting
all substances dissolved in the urine, feeding a high-
moisture diet may be considered as one of the most
effective measures to prevent CaOx formation.
Another way to increased urine volume is to stimulate
drinking by increasing dietary Na intake(21,22). This effect
of a higher Na intake might explain the results of the pre-
viously mentioned retrospective case–control study with
173 cats, in which diets high in Na (0·34 to 0·89 g/MJ
metabolisable energy (ME)) were correlated with a
decreased risk of CaOx urolith formation(9). In humans,
an increased salt intake has been associated with elevated
urinary Ca excretion(23–25). Salt-induced calciuria is
believed to result from Na–Ca interactions in the kidney,
in both the proximal and distal tubule. Reabsorption of
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Fig. 2. Schematic model of dietary risk factors likely to increase calcium oxalate urolith formation in cats. GAG, glycosaminoglycan. * This box contains dietary
factors affecting the availability of exogenous oxalate for absorption in the gastrointestinal tract. † This box contains dietary factors affecting endogenous
oxalate synthesis.
J. C. Dijcker et al.98
N
u
tr
it
io
n
R
es
ea
rc
h
R
ev
ie
w
s
Ca parallels the reabsorption of Na in the proximal tubule
and loop of Henle. Na may influence renal reabsorption of
Ca in the distal tubule by both a direct effect and indirectly
through its effects on parathyroid hormone levels(26). In a
study with healthy cats, the total daily amount of Ca
excreted in urine was reported to be increased(27). Similar
results were found in dogs(28,29). However, in two studies
with healthy adult cats, dietary Na levels of up to 0·96 g/
MJ ME did not increase urine Ca concentrations, but did
increase the volume of water drunk, resulting in a larger
urine volume and a concomitant decrease in urine specific
gravity and CaOx relative supersaturation (RSS)(30,31).
A possible explanation for this discrepancy might be that
an increased dietary Na intake enhances urinary total Ca
excretion as seen in humans, but by augmenting urine
volume, does not lead to substantially elevated urine Ca
concentrations(9,27).
Overall, research indicates that the urine volume in cats
can be increased successfully by feeding a high-moisture
diet, as well as by increasing dietary Na intake. An
increased Na intake might be used as a preventative
measure for CaOx formation as there is no evidence that
dietary Na induces elevated Ca concentrations in the
urine of healthy cats, and there are no adverse long-term
effects reported for this nutrient on, for example, blood
pressure and kidney functioning as well(32,33). However,
the effectiveness of increased dietary Na intake on
reducing CaOx urolith formation in urolith-forming cats
has not been tested.
Urinary oxalate
Since oxalate forms a relatively insoluble salt with Ca ions
at physiological pH, an increased urinary excretion of
oxalate, i.e. hyperoxaluria, can promote CaOx formation.
It has been argued that an increase in urinary oxalate
concentration promotes CaOx urolith formation to a
greater extent than comparable increases in Ca, as
changes in urinary oxalate concentration are fifteen
times as potent as equimolar changes in Ca concentration
in effecting CaOx saturation(34,35). Therefore, hyperoxa-
luria is generally accepted as a critical factor of CaOx
urolithiasis(36). To be able to reduce urinary oxalate
excretion, it is essential to understand the origin of the
oxalates excreted in the urine of cats. Both the intake of
dietary oxalate (exogenous oxalate) and biosynthesis of
oxalate (endogenous oxalate) contribute to the amount
of oxalate excreted with the urine.
Factors influencing urinary oxalate: exogenous urinary
oxalates. Intake of dietary oxalate is a known factor
that increases urinary oxalate excretion. The amount of
dietary oxalate available for absorption in the gastrointesti-
nal tract is dependent on the amount of free oxalate
present in the diet, dietary components which can
form complexes with free oxalate (for example, Ca, Mg)
and the activity of oxalate-degrading bacteria in the
gastrointestinal tract of man and animals.
In general, large amounts of oxalate are present in green
leafy vegetables and bran concentrates, moderate amounts
in nuts and cereals, and low amounts in dairy products,
meat and fish(37,38). The contribution of dietary oxalate
intake to urinary oxalate excretion in free-roaming cats is
unknown, but can be expected to be low, as the natural
(carnivorous) diet of the cat is mainly composed of food/
prey items that contain low amounts of oxalate(39,40).
In contrast, omnivorous diets (for example, for humans
and rats) contain moderate to high levels of oxalate, which
may result in a relatively high contribution of exogenous
oxalate to total urinary oxalate excretion. In humans, con-
tributions of dietary oxalate to urinary oxalates have been
reported, with estimates ranging from 25 to 68 %(41,42).
Unfortunately, no such data are available in cats.
In thirty different dry pet foods for adult small
breed dogs, the oxalate content was found to range
between 9·6 and 60·0 mg/MJ ME (4–25 mg/100 kcal) with
a mean of 26·3 mg/MJ ME (11 mg/100 kcal)(43). In a
canned diet designed to assist in the management of
LUTD in dogs, the oxalate content was 5·9 mg/MJ ME
(2·5 mg/100 kcal)(44). The average daily intake of oxalate
(2·5–15·5 mg/kg body weight (BW) per d) in dogs fed
these commercial dry diets can be considered to be
relatively high compared with the average oxalate intake
(2–3 mg/kg BW per d) by humans(43). Stevenson et al.(43)
studied the relative effects of dietary Ca and oxalate
on the composition of urine by feeding healthy dogs
a diet supplemented with 24·0 to 60·0 mg oxalate/MJ
(10–25 mg/100 kcal) and varying the dietary Ca contents.
These authors found that the oxalate excretion inconsist-
ently increased with a higher oxalate intake only when
dietary Ca intake was low (molar Ca:oxalate ratio , 18).
With higher dietary Ca:oxalate ratios (. 25) the oxalate
excretion remained low and stable, irrespective of dietary
oxalate content. The variation between dogs when differ-
ent oxalate levels were fed, in conjunction with a low diet-
ary Ca content, was very high, with effects ranging from
0 to a 400 % increase in urinary oxalate excretion. These
results indicate that the contribution of dietary oxalate to
urinary oxalate excretion in dogs is dependent on the
dietary Ca content, and is expected to be low with a
high (. 40) molar Ca:oxalate ratio in the diet.
Other factors than dietary Ca are also known to influ-
ence intestinal oxalate absorption. A similar role for dietary
Mg has been found(45). Both minerals can directly interact
with oxalate to form an insoluble complex to lower the
free oxalate concentration in the gastrointestinal tract(45),
resulting in a reduction in the absorption of oxalate(42,46,47).
Fat and phosphate can act as scavengers for Ca, thereby
indirectly increasing the availability of oxalate for uptake
by the intestine(48,49). In addition, oxalate-degrading
bacteria, such as Oxalobacter formigenes present in the
intestinal tract of man and rats, are known to reduce the
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contribution of exogenous urinary oxalates to total urinary
oxalates, as this bacterium uses oxalic acid (or its anion
oxalate) as its sole energy source by degrading oxalic
acid to formate(50,51). O. formigenes has also been detected
in the stool of cats and dogs(52,53). Lactic acid bacteria have
also been shown to degrade oxalates in vitro(54). The
impact of oxalate-degrading bacteria in the gastrointestinal
tract of humans and animals on urinary oxalate excretion
remains to be clarified.
Research in dogs indicates that, although canine foods
contain relatively high levels of oxalate, the contribution
of exogenous oxalates to the urinary oxalate excretion is
expected to be of minor importance mainly due to the
high molar Ca:oxalate ratio in commercial canine foods.
The influence of factors other than dietary Ca that are
known to affect intestinal oxalate absorption in humans
is not known in dogs and cats, but is expected to be of
minor importance in practice, as the dietary Mg content
in the majority of commercial foods is approximately 10-
fold lower than the Ca content, and dietary Ca and phos-
phate are normally balanced. Oxalate and Ca contents of
dry commercial feline diets may be expected to be in the
same range as canine foods, as similar ingredients are
used. This would imply that the potential contribution of
exogenous oxalates to total urinary oxalate excretion by
domestic cats is expected to be marginal as well, as the
Ca:oxalate ratio can be expected to be high. However,
the oxalate content of commercial feline foods and its
contribution to urinary oxalate excretion remains to be
determined in order to ascertain its relative importance.
Factors influencing urinary oxalate: endogenous urinary
oxalates. Since hyperoxaluria in humans is recognised as
an important risk factor for CaOx urolith formation, many
studies (mainly in rodents) have been conducted to unra-
vel the aetiopathogenesis of hyperoxaluria. Studies in
human subjects and rodents have revealed that the largest
part of the endogenous oxalate formation originates from
the conversion of sugars (including glucose and fructose),
amino acids (including hydroxyproline, glycine, serine,
phenylalanine, tyrosine and tryptophan) and/or glycolate,
ending via the metabolism of glyoxylate to oxalate.
Another precursor that can give rise to oxalate is ascorbic
acid, which can break down non-enzymically in urine to
produce oxalate, a reaction which is accelerated at alkaline
pH. Originally it was thought that 40 to 50 % of urinary
oxalate was derived from the breakdown of ascorbic
acid(42,55–57). However, close scrutiny of the experimental
procedures indicates that the breakdown occurred due to
processing of urine at alkaline pH(58). In cats, ascorbate
has not been found to be an important dietary precursor
of oxalate(59), indicating that endogenous oxalate biosyn-
thesis in cats relies predominately on glyoxylate
metabolism.
Endogenous biosynthesis of oxalate occurs mainly in the
liver(60) and is highly dependent on the glyoxylate content
in the hepatocytes (Fig. 3). Any glyoxylate that is not
reduced to glycolate or transaminated to glycine is oxidised
to oxalate, a reaction catalysed by cytosolic L-lactate
dehydrogenase(61) (Fig. 3(a), step I). Since oxalate can be
considered a metabolic ‘end-waste-product’ it will be
quantitatively excreted in the urine, mainly via glomerular
filtration. Oxalate excretion also occurs in the proximal
tubule after a high oral oxalate load(62,63). The most
efficient way of reducing urinary endogenous oxalate
excretion is to reduce the content of glyoxylate in the
hepatocyte (Fig. 3). This can be achieved in two ways:
by supplying less dietary precursors for glyoxylate
production in the hepatocyte or by metabolic removal of
glyoxylate from oxalate synthesis.
Glyoxylate removal can be achieved through the
conversion into glycine, which is catalysed by serine:
pyruvate aminotransferase/alanine:glyoxylate aminotrans-
ferase, also called alanine:glyoxylate aminotransferase 1
(AGT1)(64) (Fig. 3(a), step II). This enzyme can also convert
serine into hydroxypyruvate. An essential cofactor for
AGT1 is pyridoxine, or vitamin B6. A deficiency in pyridox-
ine can lead to a shift from glyoxylate removal through
conversion into glycine, to glyoxylate oxidation to oxalate.
This shift has been well documented in cats. In a study
with kittens that were fed a pyridoxine-deficient diet, a
significantly higher daily urinary oxalate excretion was
observed(65).
Glyoxylate can also be converted into glycolate (Fig. 3(a),
step III) via the action of the enzyme glyoxylate reductase/
hydroxypyruvate reductase (GR/HPR), a 2-hydroxy-acid
dehydrogenase. GR/HPR also catalyses the reduction of
hydroxypyruvate to D-glycerate (Fig. 3(a), step IV) and
the oxidation of D-glycerate to hydroxypyruvate(66). In
the human liver, GR/HPR is found predominantly in the
cytosol (. 90 %), with a small portion in the mitochon-
dria(67). In cats, GR/HPR localisation has been reported to
predominantly occur in the cytosol(68).
The existence and importance of the conversions of
glyoxylate into glycine and glycolate in the hepatocyte
has been discovered as a result of extensive research into
two severe autosomal-recessive disorders leading to mild
to severe hyperoxaluria in humans. These disorders are
termed primary hyperoxaluria (PH) and two types can be
distinguished. PH type I is an inherited disorder of glyoxy-
late metabolism arising from a deficiency in AGT1, leading
to a disrupted conversion of glyoxylate into glycine
(Fig. 3(a), step II). PH type II is an inherited disease
caused by mutations in GR/HPR, leading to a reduced con-
version of glyoxylate into glycolate (Fig. 3(a), step III) and
that of hydroxypyruvate into D-glycerate (Fig. 3(a), step
IV)(69,70). PH type II patients have a limited ability to con-
vert D-glycerate into hydroxypyruvate, resulting in most
cases in an elevated concentration of L-glycerate in the
urine, as metabolic removal of D-glycerate occurs via con-
version into L-glycerate (Fig. 3). The reported cases of PH
in cats(71,72) reflect those of human PH type II(68), while
J. C. Dijcker et al.100
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cases of PH in cats analogous to human PH type I are
unknown.
Highly notable is the observation that the spatial
localisation of AGT1 seems to be species dependent. In
carnivores and insectivores, AGT1 is mainly present in
mitochondria(73,74), while in the human liver an almost
exclusive peroxisomal localisation of this enzyme has
been reported(75). The mitochondrial localisation of AGT1
is seen in carnivorous and insectivorous species of differ-
ent genera (mammals, birds, reptiles)(73), indicating that
AGT1 localisation in the mitochondrion might be a neces-
sity when consuming high-protein, low-carbohydrate diets.
Interestingly, the Gly170Arg in combination with the
Pro11Leu mutation in the gene AGXT, encoding for
AGT1, which are commonly found in human patients
with PH type I, targets AGT1 to mitochondria instead of
to its normal location in peroxisomes(75), resembling
the mitochondrial localisation of hepatic AGT1 in
carnivores(74). Herbivores, such as Old World monkeys
(macaques and baboons), rabbits and guinea-pigs, have
most, if not all of their AGT1 located in peroxisomes(74).
Rodents (rats, mice, hamsters) and marmosets (New
World monkey) have AGT1 distributed approximately
equally between both organelles. The interspecies differ-
ence in intracellular localisation of hepatic AGT1 may
very well be the result of dietary selection pressure
during evolution(74).
Genomic expression analyses have revealed that the
adaptive shift in AGT1 targeting among species can be
ascribed to the use of alternative transcription- and trans-
lation-initiation sites of the single-copy AGXT gene(76,77).
The longest transcript of AGXT, as found in cats, encodes
a cleavable N-terminal mitochondrial targeting sequence
(MTS) and C-terminal peroxisomal targeting sequences
for peroxisomal uptake, in which MTS is dominant over
peroxisomal targeting sequences in determining the final
subcellular destination of AGT1(76,77). Species such as
man and rabbits expressing AGT1 almost exclusively in
peroxisomes have lost the first translation start site during
evolution resulting in an MTS-lacking protein. In cats and
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other species expressing AGT1 almost exclusively in
mitochondria, almost all encoded proteins contain the MTS
due to the loss of the – more downstream – second
transcription-initiation site(74,77). Species in which hepatic
AGT1 is roughly equally distributed between both
organelles utilise both translation-initiation sites(78).
It has been postulated that the dual localisation of AGT1 in
the liver is a reflection of its dual physiological function:
that is, its role in glyoxylate detoxification in peroxisomes
and its role in gluconeogenesis in mitochondria(64,74).
Intraperoxisomal glyoxylate detoxification is essential in
herbivores, since their diet is rich in glycolate and carbo-
hydrates. To prevent oxidation of cytosolic glyoxylate
to oxalate by L-lactate dehydrogenase (Fig. 3(a), step I), a
high activity of intraperoxisomal AGT1 is required. High
levels of glycolate and carbohydrates in combination with
a scarcity of animal protein (containing L-hydroxyproline,
glycine, serine), typically found in diets of herbivores,
retard the need for directing hydroxyproline-derived
glyoxylate into gluconeogenesis by conversions facilitated
by AGT1 (Fig. 3(a), step II). In contrast, carnivores
and insectivores are likely to have consumed a very low
amount of glycolate and carbohydrates during evolution
and these species have not required intensive detoxification
of glyoxylate in the peroxisome. In contrast, the high
animal protein and low carbohydrate content of the diet
of carnivores and insectivores would clearly favour the
contribution of gluconeogenesis in the mitochondrion(64).
As stated earlier, the glyoxylate content in the hepatocyte
is also dependent on certain dietary precursors. In human
medicine, it has been demonstrated that a high intake of
amino acids (i.e. hydroxyproline, serine, glycine, phenyl-
alanine, tyrosine and tryptophan)(78–83) or sugars (i.e.
glucose, fructose, galactose, xylose)(84–89) stimulates oxa-
late synthesis from the intermediate product glyoxylate.
Knight et al.(90,91) showed that hydroxyproline is a potent
contributor to urinary oxalates, with glycine contributing
little to the endogenous production of glycolate or oxalate.
In cats, the endogenous synthesis of oxalate has not
been widely studied. A study by Zentek & Schulz(92)
describes the effects of various dietary protein sources
(collagen tissue, horse meat and soya isolate) on urine
composition, including urinary oxalate excretion. Uptake
of the (high)-protein diet with collagen as the protein
source resulted in an increase in urinary oxalate excretion
(2·83 (SD 0·89) mg/kg BW per d) compared with the (high)-
protein diets with horse meat and soya protein isolate
as the protein source (0·94 (SD 0·29) mg/kg BW per d
and 1·17 (SD 0·53) mg/kg BW per d, respectively). Since
the hydroxyproline content of collagen tissue is high
(about 10–13 %), mitochondrial AGT1, which converts
L-hydroxyproline-derived glyoxylate into glycine (Fig. 3(a),
step II), might have been saturated in the cats fed the
collagen protein, leading to undesirable conversion to
oxalate by L-lactate dehydrogenase (Fig. 3(a), step I),
resulting in an increased urinary oxalate excretion(83).
Besides hydroxyproline, the amino acids glycine and
serine are also present in relatively high concentrations in
collagen tissue(93).
Zentek & Schultz(92) also investigated the effects of
different dietary protein levels on daily urinary oxalate
excretion. Of each protein source (collagen tissue, horse
meat and soya isolate), two diets were fed, one containing
a high and the other a low protein level. In the low-protein
diets, protein was exchanged with rice (carbohydrate) and
animal fat. Remarkably, all low-protein diets showed a
consistently higher daily urinary oxalate excretion. The
oxalate excretion increased approximately 5-fold (from
2·83 (SD 0·89) to 13·70 (SD 4·32) mg/kg BW per d) when
fed the low-protein diet with collagen as the protein
source compared with the high-protein diet. Urinary oxa-
late excretion increased 4-fold when changing from high-
to low-protein diets using soya isolate and horse meat as
a protein source (soya isolate diet from 1·17 (SD 0·53) to
4·79 (SD 2·73) mg/kg BW per d and the horse meat diet
from 0·94 (SD 0·29) to 3·62 (SD 2·44) mg/kg BW per d).
However, the observed increase in urinary oxalate
excretion might have been the result of a concomitant
high carbohydrate intake with the low-protein diets. As
stated earlier, in humans sugars (i.e. glucose, fructose,
galactose, xylose) are known to be a substrate for the per-
oxisomal glyoxylate pathway(84–89). It is conceivable that
when fed a high-carbohydrate diet, cats suffer an overload
of hepatic oxalate as a consequence of a deficiency in
peroxisomal AGT1 and excrete more oxalate in their
urine. Although the urinary oxalate excretion was found
to be unaffected in a study feeding healthy cats a dry com-
mercial diet with a low carbohydrate content (19·1 g/MJ
ME) v. a high carbohydrate content (34·7 g/MJ ME)(94),
the carbohydrate content of the low-carbohydrate diet in
this study can still considered to be high compared with
the carbohydrate content of the experimental diets in the
study of Zentek & Schultz(92) (i.e. collagen tissue diets:
2·7 v. 23·2 g/MJ ME; soya diets 7·1 v. 22·3 g/MJ ME; horse
meat diets 5·9 v. 25·3 g/MJ ME).
A proposed metabolic pathway for the synthesis of the
undesirable metabolite oxalate in cats from sugars is pre-
sented in Fig. 3(b). In this model, the sugars D-fructose,
D-glucose and D-galactose are first converted to D-glycerate
(Fig. 3(b), step Ia). Since the activity of fructokinase in
feline liver is found to be relatively high and that of
glucokinase to be low(95), the contribution of D-fructose
compared with D-glucose is expected to be higher.
D-Glycerate can subsequently be converted into glycolate
via the intermediates hydroxypyruvate and glycolaldehyde
(Fig. 3(b), steps Ib, Ic and Id). The sugar D-galactose(84)
can also be converted to glycolate, with only glycolalde-
hyde as an intermediate. The sugar xylose enters the
metabolic pathway to oxalate via glycolaldehyde as
well(96). Cytosolic glycolate may partly be directed into
the peroxisomes by diffusion where glycolate will be
either oxidised directly to oxalate by the enzyme glycolate
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dehydrogenase(80) (Fig. 3(b), step II) or converted to
glyoxylate by the enzyme glycolate oxidase(97) (Fig. 3(b),
step III). In most animals, the major part of this glyoxylate
will be transaminated to glycine by AGT1 (Fig. 3(b),
step IV) (i.e. peroxisomal glyoxylate detoxification), but
in cats, and other carnivores, most of this glyoxylate will
probably be converted back to glycolate due to a deficit
of AGT1 activity in the peroxisome. This surplus in
glycolate will probably result in an increased conversion
of glycolate to oxalate catalysed by glycolate dehydro-
genase (Fig. 3(b), step II).
An additional explanation for the increase in oxalate syn-
thesis upon feeding diets high in carbohydrate and low in
protein content may be a reduction of gluconeogenesis in
the liver, which results in a lower need for glycine and
serine as a gluconeogenic precursor. It is conceivable
that high concentrations of glycine and/or serine attenuate
mitochondrial AGT1 in a negative feedback loop. This
might result in an additional shift to oxalate synthesis.
Collectively, it is possible that in cats a high carbohydrate
intake is a potential risk factor for CaOx urolith formation
by increasing endogenous oxalate synthesis.
The prevention of oxalate synthesis in cats by expressing
AGT1 almost exclusively in the mitochondrion can be
considered as one of the many enzymic adaptations as a
result of their obligatory carnivorous lifestyle throughout
evolution. By expressing AGT1 almost exclusively in the
mitochondrion, the formed glyoxylate (mainly originating
from hydroxyproline) is efficiently transaminated to
glycine (Fig. 3(a), step II), which can directly be used for
intramitochondrial gluconeogenesis. This enzymic adap-
tation appears to be part of a long list of adaptations in
this species, such as cysteine dioxygenase and cysteinesul-
finate decarboxylase (taurine synthesis), pyrroline-
5-decarboxylase and ornithine aminotransferase (citrulline
synthesis), dioxygenase (retinol synthesis), glucokinase
(glucose metabolism), 7-hydroxycholesterol-D7 reductase
(25-hydroxycholesterol synthesis) and picolinic carboxy-
lase (nicotinic acid synthesis)(39,98).
Dietary factors influencing endogenous urinary oxalate
synthesis. In cats, urinary oxalate excretion has been
found to be inversely correlated with protein intake and
dependent on the protein source(92), although the inverse
correlation with protein intake might be the result of a
higher carbohydrate intake. In contrast, in human subjects
some studies reported that urinary oxalate excretion
increased with increased dietary protein intake and
decreased with protein restriction(99,100). This might be
explained by the distinct subcellular AGT1 distribution in
humans and cats.
AGT1 catalyses the hepatic transamination of glyoxylate,
being an important precursor of oxalate, to glycine(101).
Pyridoxine, or vitamin B6, is a known cofactor for
AGT1(102) and, as such, pyridoxine deprivation could
indirectly elevate endogenous oxalate biosynthesis and,
in turn, its urinary excretion(103–105). Indeed, the daily
urinary oxalate excretion was higher in kittens fed a
pyridoxine-deficient diet compared with those receiving
adequate amounts of pyridoxine(65,106). Moreover,
pyridoxine can act as a cofactor for various enzymes in
the tricarboxylic acid cycle as well, leading to a decreased
synthesis of citrate. Thus, under the condition of pyridox-
ine deficiency, citrate metabolism may be impaired,
leading to a lower urinary citrate concentration and
increased risk of precipitation with CaOx(103). To the
authors’ knowledge, the effect of pyridoxine on urinary
citrate excretion in cats has not been studied.
Although an excess consumption of ascorbate (i.e. vita-
min C) has been associated with increased endogenous
oxalate synthesis (by the non-enzymic oxidation of ascor-
bate to oxalate)(36,107–110) in humans, in healthy cats diet-
ary supplementation with ascorbate up to 193 mg/kg did
not affect urinary oxalate concentrations(59). However,
only the effect of a moderate and not a high amount of
ascorbate on the urinary oxalate excretion has been
tested. As cats, in contrast to man, can synthesise ascorbate
in sufficient amounts de novo from glucose, ascorbate is
not an essential nutrient(111). Although there is no evidence
that dietary ascorbate can increase urinary oxalate levels in
cats, it is generally recommended to avoid excessive
amounts of dietary ascorbate. This recommendation is
purely based on the results obtained in human subjects.
Urinary calcium
It goes without saying that an increase in urinary Ca
excretion, as one of the constituents of CaOx uroliths,
significantly contributes to CaOx formation. The question
is whether hypercalciuria is indeed a causative factor in
CaOx uroliths formation. In humans hypercalciuria is
thought to be a risk factor for, but not necessarily the
cause of, CaOx urolith formation(2).
One of the factors that can cause hypercalciuria is hyper-
calcaemia. Approximately 35 % of the cats with CaOx
uroliths also have evidence of an increase in total serum
Ca concentrations(112). On the other hand, in a study
which reported the laboratory findings, clinical course,
and treatment of twenty cats with idiopathic hypercalcae-
mia, 35 % (seven cats) had signs of urolithiasis, and in
only two cats these uroliths were composed of CaOx(113).
Although hypercalcaemia is frequently seen in cats with
CaOx urolithiasis, hypercalcaemia in itself does not seem
to be a causative factor in CaOx formation.
Another factor that is frequently indicated as a possible
cause for hypercalciuria is feeding an acidified diet. In a
case report of five cats with hypercalcaemia and CaOx uro-
lithiasis, hypercalcaemia resolved after discontinuation of
urinary acidifying therapy or dietary change, or both(114).
Controlled studies in cats have confirmed that feeding acidi-
fying diets to cats leads to increased urinary Ca excretion.
In a long-term case–control study, feeding healthy adult
cats an acidifying diet supplemented with 1·7 % phosphoric
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acid, a low urine pH (#6·4) was found, together with an
increase in urinary Ca excretion(115). Another study
reported the same effect, with the exception that only
after 1 month of feeding an acidifying diet (1·5 %
ammonium chloride added), the calciuric response
declined gradually (during 4 months)(116).
Dietary factors influencing urinary calcium excretion.
Conflicting results exist in the literature on the role of
dietary Ca in inducing and resolving hypercalciuria. For
decades, the prevailing consensus was that dietary Ca
restriction would reduce urinary Ca excretion, and as
such CaOx formation(9). However, recent literature in
humans and dogs indicates that there might be an advan-
tage of increased dietary Ca intake, which is thought to
be related to interactions between Ca and oxalate in the
intestinal lumen(44,117). When sufficient dietary Ca is avail-
able, complexation with oxalate occurs in the intestinal
lumen, which in turn results in a reduction of intestinal
absorption and renal excretion of both exogenous Ca
and oxalate. Furthermore, a retrospective case–control
study in cats revealed that consuming diets with a relatively
low amount of Ca (0·23 to 0·49 g/MJ ME) had a significantly
greater risk for CaOx urolith formation than cats that
consumed higher dietary levels of Ca(9). This association
may be explained by a higher oxalate absorption from
the gastrointestinal tract.
Low dietary intake of P may be related to an increased
urinary Ca excretion due to a lower binding of Ca by phos-
phate ions in the gastrointestinal tract resulting in an
increased Ca absorption(118). An increase in urinary Ca
excretion due to a low dietary P content could explain
the increased risk for developing CaOx uroliths in cats fed
diets containing a low P content (0·20 to 0·42 g/MJ ME)(9).
On the other hand, the same study indicates that diets with
a high P content (0·76 to 1·13 g/MJ ME) correlate with an
increased risk of CaOx urolith formation compared with
diets with moderate P content (0·66 to 0·76 g/MJ ME).
Excessive amounts of P present in the gastrointestinal tract
could compete with oxalate, preventing intestinal Ca com-
plexation with oxalate, which in turn could increase the
availability of free oxalate for intestinal absorption and
eventually renal excretion(9,119,120). The precise influence
of dietary P on hypercalcaemia and CaOx formation in cats
remains unclear and should be further studied.
Results of a retrospective case–control study revealed
that cats fed diets with relatively high K contents (0·52 to
0·77 g/MJ ME) were less than half as likely (OR 0·45) to
develop CaOx uroliths compared with cats fed diets with
low K contents (0·23 to 0·38 g/MJ ME)(9). In cats, no studies
have been conducted that may explain this relationship.
However, in human subjects, studies have observed
reduced Ca excretion after K supplementation(121,122).
The authors of these studies suggested that the decrease
in urinary Ca during K administration may be related to
the natriuretic effects of K, resulting in extracellular
fluid-volume contraction or to K-induced phosphate
retention and/or suppression of 1,25-dihydroxyvitamin D3
synthesis(121). Another explanation for the relationship of
a higher K content with a decrease in CaOx formation is
the alkalising effect of K salts, leading to a higher urine
pH and therefore a lower potential for Ca and oxalate to
precipitate. Whether these suggested mechanisms are
effective in cats should be investigated further.
Urine pH
Although the solubility of CaOx in urine is marginally
influenced by pH of 4·5 to 7·5, several epidemiological
studies have consistently identified acidifying diets (con-
taining acidifying components such as phosphoric acid,
ammonium chloride or D,L-methionine) as one of the
most prominent risk factors for cats(9,10,13). The influence
of urine pH on CaOx formation in cats was confirmed in
a study feeding urine-acidifying, basal, and alkalinising
diets to cats during 12 months (resulting in urine pH of
6·2 (SD 0·1), 6·8 (SD 0·2) and 7·2 (SD 0·3), respectively).
Significant differences in urine saturation for CaOx were
found: the highest saturation occurring in cats consuming
the acidifying diet and the lowest saturation occurring in
cats consuming the alkalinising diet(123). Compared with
cats, a less prominent association with dietary acidifying
potential was found in dogs, especially when fed canned
diets(124). It has been suggested that urine pH may affect
the potency of CaOx crystallisation inhibitors, such
as chondroitin sulfate and citrate(125). Another possible
explanation is that acidifying diets increase urinary Ca
excretion. Since there is a correlation between the base
excess in the food and the average urine pH(126–128), an
acidified diet induces persistent aciduria which is associ-
ated with low-grade metabolic acidosis. This metabolic
acidosis induces bone mobilisation, which results in an
increased urinary Ca excretion(115,116,129). Another mecha-
nism of acidified urine to result in elevated Ca excretion
is by inhibition of Ca reabsorption in the distal renal
tubule(114). Luminal protons directly inhibit transepithelial
Ca reabsorption in the kidney by altering the conformation
of the Ca-selective channel TRPV5 located in the apical
membrane of the distal renal tubule(130).
Although the cause of acidosis-induced hypercalcaemia
in cats has not been identified, it is possible that acidosis
affects the activity of TRPV5 in osteoclasts as well, which
plays a critical role in bone formation and maintenance
of serum Ca(131). From the literature it appears that a
dietary-induced decrease in urine pH affects the Ca
excretion in the urine of cats, although the long-term
effect remains questionable(115,116).
As an elevated Ca concentration in the urine can be
considered as a risk factor for CaOx urolith formation, it
might be reasonable to assume that a decrease in urine
pH might affect the RSS of CaOx. However, some studies
have claimed no correlation between urinary pH and
CaOx RSS(132,133). Since the RSS is thought to serve as a
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predictor of CaOx urolith formation(134), these findings
suggest that factors other than urine pH play a role in
CaOx urolith formation as well. However, it is important
to note that, although the value for urinary RSS with
CaOx is higher in urolith-forming dogs and cats, no pro-
spective studies are available to confirm that a high RSS
value indeed correlates with increased frequency of
CaOx urolith recurrence(28,135).
Dietary factors influencing urine pH. Dietary protein of
animal origin may decrease the base excess of the diet and
increase the acid intake. As described above, a high acid
intake can result in an increase in urinary Ca excretion. It
can also reduce urinary citrate excretion since protons
are able to associate with citrate in the intestine and
kidney(136). This mechanism might explain why humans
do have a higher risk for CaOx formation following the
consumption of high amounts of animal protein(99,137). In
cats, however, an opposite effect has been found. In a
retrospective case–control study it was demonstrated that
cats fed diets containing high amounts of protein (25·1 to
33·0 g/MJ ME) were less than half as likely (OR 0·44) to
develop CaOx urolithiasis compared with cats receiving
low amounts of protein (12·4 to 18·9 g/MJ ME)(9). A possible
explanation might be that in cats the consumption of animal
protein is often accompanied by stimulated water consump-
tion, eventually resulting in an increase in urine volume, and
an increased P excretion without altering Ca excretion(20).
The observed lower oxalate excretion in healthy cats fed a
high-protein diet compared with a low-protein diet(92)
might explain this association as well (Fig. 3).
The precise mechanism in which urinary Mg may
influence CaOx formation is still largely unknown.
Originally, Mg was thought to act as a mild inhibitor of
CaOx crystallisation(138). Another plausible explanation is
that Mg, given as alkali salts, increase the urine pH, which
in turn stimulates urinary citrate excretion by the kidney,
which reduces the risk of CaOx crystal formation(139,140).
A retrospective case–control study in cats revealed that
diets with a low Mg content (22 to 43 mg/MJ ME) were
associated with CaOx urolith formation(9). Several studies
(in other species) have reported an association between
low dietary Mg and CaOx urolith formation as
well(139,141–143). In addition, in human medicine an
increased dietary intake of Mg salts (containing citrate) is
recommended in patients suffering from CaOx urolithia-
sis(139,144,145). An additional mechanism of action is the for-
mation of complexes between Mg and oxalate, thereby
reducing the supersaturation with CaOx. However, in a
study with cats fed a diet with a high Mg concentration,
despite a significant increase in urinary Mg, no significant
effect was observed regarding urinary CaOx crystal
growth inhibition, agglomeration inhibition or solubility,
compared with the base diet(146). Interestingly, in the ear-
lier mentioned retrospective case–control study, diets
high in Mg content (86 to 336 mg/MJ ME) were associated
with a higher risk for CaOx urolith formation compared
with diets with a moderate Mg content (43–86 mg/MJ
ME)(9). An explanation might be that in cats the contri-
bution of dietary oxalate to urinary oxalate excretion is
less prominent and therefore complexation of oxalate in
the gastrointestinal tract by Mg less effective. Moreover,
in cats there is no evidence that hypocitrauria is a risk
factor for CaOx urolith formation.
Urinary citrate
Citrate synthesised by the kidney or derived from the diet
is one of the most abundant organic anions in urine and
has two main functions. First, it prevents alkaline-induced
calcium phosphate stone formation by permitting base
excretion without raising urine pH. Second, urinary citrate
acts as a chelator of Ca and is therefore considered to be
the best natural inhibitor of CaOx urolith formation(147).
The higher the citrate concentration in the urine, the less
Ca is available to form CaOx crystals. As a consequence,
a deficiency of urinary citrate caused by renal or gastroin-
testinal disorders is often seen in humans with CaOx
stone disease(148,149). However, there is no evidence that
hypocitrauria is a risk factor for CaOx urolith formation
in cats. In dogs with CaOx urolithiasis, no hypocitrauria
was reported(150).
In order to increase the citrate concentration in the urine,
potassium or sodium citrate is added to the majority of the
CaOx urolithiasis therapeutic diets. However, there have
been no studies in cats investigating the effects of dietary
citrate addition on citrate concentrations in the urine or
the formation of CaOx. In healthy dogs, supplementation
of dietary potassium citrate did not result in a consistent
increase in urinary citrate excretion(151). In this study,
only a small, but not significant, increase in urine pH
was observed. This increase in urine pH might be ben-
eficial, although the influence of the urine acidity on
CaOx formation remains questionable.
Urinary glycosaminoglycans
GAG comprise another class of components affecting stone
formation. They can act in two ways: GAG, chondroitin
sulfate and heparin sulfate are freely excreted in
the urine and can inhibit the growth of CaOx crystals.
Secondly, GAG are part of the extracellular matrix and
can cover the inner wall of the bladder to form a defence
against microbial and crystal adherence(152). In cats with
FIC, compared with healthy cats, a lower urinary GAG
excretion has been detected, indicating that the defence
against microbial and crystal adherence and inhibition of
CaOx growth is decreased(153). Oral supplementation of
GAG in order to increase the free GAG concentration in
urine has been shown to have a moderate to significant
beneficial effect in humans with interstitial and radial cysti-
tis(154). In a study where oral glucosamine supplementation
(i.e. 125 mg N-acetyl glucosamine) was compared with a
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placebo control group in order to manage cats with FIC,
no significant difference in urinary GAG concentration
between the two groups was observed(17). Surprisingly,
the majority of the cats receiving the N-acetyl glucosamine
did improve clinically, as was also the case for cats in the
placebo group. According to Gunn-Moore & Shenoy(17),
the improvement in both groups can be explained by the
significant decrease in urine specific gravity that was
found in about 90 % of the subjects (of both treatment
and placebo groups). It is likely that this positive effect
was due to the fact that the owners decided to feed their
cats more moist food during this study and not due to
the N-acetyl glucosamine treatment.
Conclusions
Most of the dietary modifications to reduce CaOx urolith
formation in cats and dogs are mainly based on data
from epidemiological studies in these species and clinical
studies in human subjects and rodents. Controlled studies
designed to evaluate the efficacy of these dietary modifi-
cations in cats are scarce. To be able to improve the
preventative measures (i.e. dietary modifications) against
CaOx urolithiasis in cats, it is important to study the
aetiopathogenesis of CaOx urolithiasis.
In contrast to human medicine, dietary modifications to
decrease endogenous oxalate synthesis have hardly been
studied in cats and future focus should examine the
origin of urinary oxalate in cats, as a representative of
the carnivores. The exclusive mitochondrial localisation
of AGT1 in cats conforms to the notion that obligate carni-
vores, including domestic cats, are adapted to their natural
diet, i.e. eating small mammals, containing high levels of
animal protein, low levels of carbohydrate and glycolate.
The observation that most commercial cat foods contain
relatively high amounts of carbohydrates, often at the
expense of animal protein, raises the question whether
the consumption of these diets increases endogenous
oxalate synthesis and in consequence the risk of CaOx
urolithiasis. In addition, the contribution of exogenous
oxalates to urinary oxalate excretion is unknown in cats
as well. Knowledge about the dietary oxalate content in
commercial feline diets, which is expected to be higher
than in their natural diet, is essential in order to determine
the contribution of exogenous oxalates in urinary oxalate
excretion.
In-depth knowledge of feline endogenous oxalate
metabolism and dietary oxalate absorption will provide a
better understanding of the sharp increase in CaOx urolith
prevalence in cats reported over the last few decades and
provide new insights for preventative strategies. Also,
based on the fact that in many human PH type I patients
AGT1 is mistargeted to the mitochondria, mimicking the
subcellular AGT1 distribution of cats, the cat might be a
perfect research object to study endogenous oxalate
synthesis in this genetic disorder.
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